These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27282013)

  • 1. Generation Z: Adolescent Xenobiotic Abuse in the 21st Century.
    Eggleston W; Stork C
    Adolesc Med State Art Rev; 2015 Dec; 26(3):570-88. PubMed ID: 27282013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.
    Herman BH; Vocci F; Bridge P
    Neuropsychopharmacology; 1995 Dec; 13(4):269-93. PubMed ID: 8747752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving high: new designer drugs of abuse.
    Pourmand A; Armstrong P; Mazer-Amirshahi M; Shokoohi H
    Hum Exp Toxicol; 2014 Oct; 33(10):993-9. PubMed ID: 24501103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
    Bäckberg M; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Nov; 53(9):856-64. PubMed ID: 26295489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulant and Designer Drug Use: Primary Care Management.
    Klega AE; Keehbauch JT
    Am Fam Physician; 2018 Jul; 98(2):85-92. PubMed ID: 30215997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an addiction index and delineation 15-year trends of illicit drugs from the Taiwan national drug enhancement database.
    Lin C; Wong BY; Lo MT; Chiu YC; Lin YH
    J Psychiatr Res; 2020 Jan; 120():131-136. PubMed ID: 31670261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

  • 8. Designer drugs. Assess & manage patients intoxicated with ecstasy, GHB or rohypnol--the three most commonly abused designer drugs.
    Goss J
    JEMS; 2001 Jun; 26(6):84-7, 90-3; quiz 94. PubMed ID: 11409205
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ecstasy: a forgotten drug].
    Avila de Tomás JF; Salas Dueñas R; García Martín P
    Aten Primaria; 1998 Feb; 21(3):180. PubMed ID: 9607238
    [No Abstract]   [Full Text] [Related]  

  • 10. A Case of Unusual Drug Screening Results.
    Chang BN; Smith MP
    Clin Chem; 2017 May; 63(5):958-961. PubMed ID: 28455300
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ecstasy: from recreational drug to toxic substance].
    Franck N; Bertrand J
    Rev Med Liege; 1997 Nov; 52(11):715-22. PubMed ID: 9480498
    [No Abstract]   [Full Text] [Related]  

  • 12. Street drug roulette continues.
    Smith M
    Emerg Med Serv; 2002 Jun; 31(6):30. PubMed ID: 12078405
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer drugs: mechanism of action and adverse effects.
    Luethi D; Liechti ME
    Arch Toxicol; 2020 Apr; 94(4):1085-1133. PubMed ID: 32249347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in long-term relapse rates between youths with ketamine use and those with stimulants use.
    Wang LJ; Chen MY; Lin CY; Chong MY; Chou WJ; You YH; Tsai CP; Chen YS; Lu SF
    Subst Abuse Treat Prev Policy; 2018 Dec; 13(1):50. PubMed ID: 30577882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phencyclidine--angel dust].
    Høiseth G; Hjelmeland K; Bachs L
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2775-6. PubMed ID: 16244678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
    Elliott K; Kest B; Man A; Kao B; Inturrisi CE
    Neuropsychopharmacology; 1995 Dec; 13(4):347-56. PubMed ID: 8747759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ecstasy].
    Ege PP
    Ugeskr Laeger; 2000 Jul; 162(31):4161-2. PubMed ID: 10962923
    [No Abstract]   [Full Text] [Related]  

  • 19. [New therapeutic possibilities with low-affinity NMDA receptor antagonists].
    Kornhuber J; Weller M
    Nervenarzt; 1996 Jan; 67(1):77-82. PubMed ID: 8676993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classics in Chemical Neuroscience: Dextromethorphan (DXM).
    McClure EW; Daniels RN
    ACS Chem Neurosci; 2023 Jun; 14(12):2256-2270. PubMed ID: 37290117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.